Medications

How a novel drug pushes the HIV capsid to breaking point

Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first drug available to patients ...

Neuroscience

Researchers find a molecular mechanism related to neuronal death

The human brain is an organ that requires 20% to 25% of the energy the body creates. This high energy demand for neuronal functions depends on the transport and precise distribution of mitochondria—the energy-generating ...

page 3 from 40